Public Health programme overview

As the EASL Congress 2023  approaches, we would like to bring your attention to the valuable sessions in the Public Health Track of the scientific programme. This year’s congress promises to be an enlightening and engaging experience for all attendees.

Staying up to date on the latest advancements in public health and liver disease is crucial in our collective pursuit of improving patient outcomes and global liver health. By participating in the public health track sessions, you will gain insights from esteemed experts, share best practices, and contribute to the ongoing dialogue in this vital field. We encourage you to seize this opportunity to deepen your knowledge and broaden your professional network.

The sessions in this track will cover important topics such as collaboration between EASL and The Lancet Liver Commission to advance liver health in Europe, expanding access to hepatitis B diagnosis and treatment, management of hepatitis D virus (HDV) infection, challenges in screening for NAFLD and ALD, translating recommendations into action in high-risk settings, and the significance of early diagnosis and intervention for significant fibrosis in chronic liver disease. These sessions aim to provide the latest research, insights, and strategies to effectively tackle liver diseases and reduce their burden.